FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
4,165 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| Furosemide | Furosemide 10 mg/mL | Injection, SolutionIntravenous | NorthStar Rx LLC | ANDA | 72603-251 | 72603-0251-2572603-0251-25 | — |
| Furosemide | Furosemide 10 mg/mL | Injection, SolutionIntravenous | NorthStar Rx LLC | ANDA | 72603-474 | 72603-0474-2572603-0474-25 | — |
| Furosemide | Furosemide 20 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | ANDA | 72789-030 | 72789-0030-3072789-0030-60 | — |
| Furosemide | Furosemide 40 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | ANDA |
| 72789-032 |
| 72789-0032-3072789-0032-60 |
| — |
| Furosemide | Furosemide 80 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | ANDA | 72789-033 | 72789-0033-0172789-0033-3072789-0033-60+1 more | — |
|---|
| Furosemide | Furosemide 40 mg/1 | TabletOral | PD-Rx Pharmaceuticals, Inc. | ANDA | 72789-157 | 72789-0157-01 | — |
|---|
| Furosemide | Furosemide 10 mg/mL | Injection, SolutionIntravenous | Devatis Inc. | ANDA | 73043-022 | 73043-0022-01 | — |
|---|
| Furosemide | Furosemide 10 mg/mL | Injection, SolutionIntravenous | Devatis Inc. | ANDA | 73043-023 | 73043-0023-01 | — |
|---|
| Furosemide | Furosemide 10 mg/mL | Injection, SolutionIntravenous | Devatis Inc. | ANDA | 73043-024 | 73043-0024-01 | — |
|---|
| Furosemide | Furosemide 10 mg/mL | InjectionIntravenous | Maiva Pharma Private Limited | ANDA | 73542-101 | 73542-0101-25 | — |
|---|
| Furosemide | Furosemide 10 mg/mL | InjectionIntravenous | Maiva Pharma Private Limited | ANDA | 73542-102 | 73542-0102-25 | — |
|---|
| Furosemide | Furosemide 10 mg/mL | InjectionIntravenous | Maiva Pharma Private Limited | ANDA | 73542-103 | 73542-0103-25 | — |
|---|
| Furosemide | Furosemide 10 mg/mL | Injection, SolutionIntramuscular, Intravenous | Phlow Corporation | NDA | 81565-201 | 81565-0201-02 | — |
|---|
| Furosemide | Furosemide 20 mg/1 | TabletOral | Northwind Health Company, LLC | ANDA | 82868-050 | 82868-0050-3082868-0050-90 | — |
|---|
| Furosemide | Furosemide 10 mg/mL | Injection, SolutionIntramuscular, Intravenous | Avenacy Inc. | ANDA | 83634-302 | 83634-0302-0283634-0302-0483634-0302-10 | — |
|---|
| Furosemide | Furosemide 20 mg/1 | TabletOral | Ipca Laboratories Limited | ANDA | 83980-002 | 83980-0002-0183980-0002-1083980-0002-97 | — |
|---|
| Furosemide | Furosemide 40 mg/1 | TabletOral | Ipca Laboratories Limited | ANDA | 83980-003 | 83980-0003-0183980-0003-1083980-0003-97 | — |
|---|
| Furosemide | Furosemide 80 mg/1 | TabletOral | Ipca Laboratories Limited | ANDA | 83980-004 | 83980-0004-0183980-0004-0583980-0004-10+1 more | — |
|---|
| Furosemide | Furosemide 10 mg/mL | Injection, SolutionIntravenous | ProPharma Distribution | ANDA | 84549-251 | 84549-0251-25 | — |
|---|
| Furosemide | Furosemide 10 mg/mL | Injection, SolutionIntravenous | ProPharma Distribution | ANDA | 84549-474 | 84549-0474-25 | — |
|---|
| Furosemide | Furosemide 20 mg/1 | TabletOral | Unit Dose Solutions, Inc. | ANDA | 87441-033 | 87441-0033-01 | — |
|---|
| Fusariumfusarium solani | Haematonectria haematococca .1 g/mL | InjectionCutaneous, Intradermal, Subcutaneous | Allermed Laboratories, Inc. | BLA | 49643-111 | 49643-0111-0549643-0111-1049643-0111-30+1 more | — |
|---|
| Fusarium Mixgibberella fujikuroi and fusarium solani | Haematonectria haematococca .025 g/mL; Gibberella fujikuroi .025 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-9636 | 22840-9636-0222840-9636-04 | — |
|---|
| Fusarium Mixgibberella fujikuroi and fusarium solani | Haematonectria haematococca 20000 [PNU]/mL; Gibberella fujikuroi 20000 [PNU]/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-9637 | 22840-9637-0222840-9637-04 | — |
|---|
| Fusarium Mixgibberella fujikuroi and fusarium solani | Haematonectria haematococca 10000 [PNU]/mL; Gibberella fujikuroi 10000 [PNU]/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-9638 | 22840-9638-04 | — |
|---|
| Fusarium Mixgibberella fujikuroi and fusarium solani | Haematonectria haematococca .0005 g/mL; Gibberella fujikuroi .0005 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-9639 | 22840-9639-01 | — |
|---|
| Fusarium Mixgibberella fujikuroi and fusarium solani | Haematonectria haematococca .0125 g/mL; Gibberella fujikuroi .0125 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-9641 | 22840-9641-0222840-9641-0422840-9641-05 | — |
|---|
| Fusarium moniliforme | Gibberella fujikuroi .1 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1670 | 22840-1670-0222840-1670-04 | — |
|---|
| Fusarium moniliforme | Gibberella fujikuroi 20000 [PNU]/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1671 | 22840-1671-0222840-1671-04 | — |
|---|
| Fusarium moniliforme | Gibberella fujikuroi .05 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1672 | 22840-1672-02 | — |
|---|
| Fusarium moniliforme | Gibberella fujikuroi 40000 [PNU]/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1673 | 22840-1673-02 | — |
|---|
| Fusarium moniliforme | Gibberella fujikuroi .001 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1674 | 22840-1674-01 | — |
|---|
| Fusarium moniliforme | Gibberella fujikuroi .05 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-5618 | 22840-5618-0222840-5618-0422840-5618-05 | — |
|---|
| Fusarium solani | Haematonectria haematococca .025 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1676 | 22840-1676-02 | — |
|---|
| Fusarium solani | Haematonectria haematococca 20000 [PNU]/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1677 | 22840-1677-02 | — |
|---|
| Fusarium solani | Haematonectria haematococca .001 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-1678 | 22840-1678-01 | — |
|---|
| Fusarium solani | Haematonectria haematococca .025 g/mL | SolutionIntradermal, Percutaneous, Subcutaneous | Greer Laboratories, Inc. | BLA | 22840-5619 | 22840-5619-0222840-5619-0422840-5619-05 | — |
|---|
| FUSIDYNE DERMA TROUBLE Zinc Calming Sunscreenzinc oxide | Zinc oxide 8.463275 g/50mL | LotionTopical | DONG WHA PHARM. CO., LTD. | OTC monograph drug | 51352-999 | 51352-0999-11 | — |
|---|
| Fusion Water Magicoctocrylene, homosalate, octisalate, and avobenzone | Octocrylene 90 mg/mL + 3 more ingredients | LotionTopical | ISDIN Corp. | OTC monograph drug | 69494-016 | 69494-0016-0169494-0016-02 | — |
|---|
| Future Youth Daily Turnaround Hydrating Moisturizer SPF 50avobenzone, homosalate, octisalate, and octocrylene | Octisalate 5 g/100mL + 3 more ingredients | CreamTopical | Pacifica Beauty, LLC | OTC monograph drug | 61197-219 | 61197-0219-00 | — |
|---|
| Futurist Hydra Rescue Moisturizing Makeup Broad Spectrum SPF 45ensulizole, octinoxate, octisalate, and zinc oxide | Ensulizole 27 mg/mL + 3 more ingredients | LiquidTopical | ESTEE LAUDER INC | OTC monograph drug | 11559-058 | 11559-0058-01 | — |
|---|
| Futurist Hydrating Collagen-Peptide Makeup Broad Spectrum SPF 20octinoxate and titanium dioxide | Octinoxate 40 mg/mL; Titanium dioxide 15 mg/mL | LotionTopical | ESTEE LAUDER INC | OTC monograph drug | 11559-066 | 11559-0066-01 | — |
|---|
| Futurist Skin Tint Serumoctinoxate,octisalate,zinc oxide | Zinc oxide 68 mg/mL + 2 more ingredients | CreamTopical | ESTEE LAUDER INC | OTC monograph drug | 11559-063 | 11559-0063-01 | — |
|---|
| Fuzion AB Foambenzalkonium chloride | Benzalkonium chloride .13 g/100mL | LiquidTopical | Zep Inc. | OTC monograph drug | 66949-111 | 66949-0111-16 | — |
|---|
| FUZYAT 5% Minoxidil Hair Growth for Men and Women5% minoxidil hair growth spray for men and women | Minoxidil 5 g/100mL | SprayTopical | Guangzhou Jingliang Cosmetics Co., Ltd. | OTC monograph drug | 87408-015 | 87408-0015-01 | — |
|---|
| FW Extra Strength AF Smooth Antacidcalcium carbonate | Calcium carbonate 750 mg/1 | Tablet, ChewableOral | Family Dollar Services, Inc. | OTC monograph drug | 55319-925 | 55319-0925-23 | — |
|---|
| Fyarrosirolimus | Sirolimus 5 mg/mL | Injection, Powder, Lyophilized, For suspensionIntravenous | Aadi Bioscience, Inc. | NDA | 80803-153 | 80803-0153-50 | — |
|---|
| Fyavolvnorethindrone acetate and ethinyl estradiol | Ethinyl estradiol .0025 mg/1; Norethindrone acetate .5 mg/1 | Tablet, Film coatedOral | Lupin Pharmaceuticals, Inc. | ANDA | 68180-827 | 68180-0827-0968180-0827-73 | — |
|---|
| Fyavolvnorethindrone acetate and ethinyl estradiol | Ethinyl estradiol .005 mg/1; Norethindrone acetate 1 mg/1 | Tablet, Film coatedOral | Lupin Pharmaceuticals, Inc. | ANDA | 68180-828 | 68180-0828-0968180-0828-73 | — |
|---|
| Fycompaperampanel | Perampanel 2 mg/1 | TabletOral | Eisai Inc. | NDA | 62856-272 | 62856-0272-1462856-0272-3062856-0272-90 | — |
|---|